Logo

Rockwell Medical, Inc.

RMTI

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin… read more

Healthcare

Drug Manufacturers—Specialty & Generic

25 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$1.02

Price

-2.86%

-$0.03

Market Cap

$34.858m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$97.727m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$264k

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$0.01

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$31.522m

$53.961m

Assets

$22.439m

Liabilities

$12.868m

Debt
Debt to Assets

23.9%

5.5x

Debt to EBITDA
Free Cash Flow

$2.223m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases